Treatment beyond progression in non-small cell lung cancer: A systematic review and meta-analysis.

ABSTRACT:

Objectives

Treatment beyond progression (TBP) is defined as treatment continuing in spite of disease progression, according to the Response Evaluation Criteria In Solid Tumors. We performed a systematic review and meta-analysis to provide evidence for the effects of TBP on lung cancer survival.

Materials and methods

This study has been conducted following the PRISMA guidelines. A systematic review of PubMed, MEDLINE, Embase, and Cochrane Collaboration Central Register of Controlled Clinical Trials from the inception of each database to December 2021 was conducted. Two authors independently reviewed articles for inclusion and extract data from all the retrieved articles. Random-effects meta-analysis was performed using Comprehensive Meta-Analysis software, version 3 (Biostat,

SUBMITTER: Kuo WK 

PROVIDER: S-EPMC9713814 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature